THE DRUG TREATMENT OF DUODENAL ULCER: PHYSIOLOGICAL CONSIDERATIONS IN THE CHOICE OF THERAPY
- 1 April 1986
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 16 (2), 263-267
- https://doi.org/10.1111/j.1445-5994.1986.tb01176.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- COMPARISON OF TRI-POTASSIUM DI-CITRATO BISMUTHATE TABLETS WITH RANITIDINE IN HEALING AND RELAPSE OF DUODENAL ULCERSThe Lancet, 1985
- Double blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcers.BMJ, 1985
- RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL ULCER RELAPSE *1A Double-blind, Randomised, Multicentre, Comparative TrialThe Lancet, 1984
- RELAPSE RATES IN DUODENAL ULCER PATIENTS FORMERLY TREATED WITH BISMUTH SUBCITRATE OR MAINTAINED WITH CIMETIDINEThe Lancet, 1984
- RANITIDINE 150 mg TWICE DAILY VS 300 mg NIGHTLY IN TREATMENT OF DUODENAL ULCERSThe Lancet, 1984
- Omeprazole in Zollinger–Ellison SyndromeNew England Journal of Medicine, 1984
- Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.Gut, 1983
- RAPID HEALING OF DUODENAL ULCERS WITH OMEPRAZOLE: DOUBLE-BLIND DOSE-COMPARATIVE TRIALThe Lancet, 1983
- DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATEThe Lancet, 1981
- Healing of Duodenal Ulcer with an Antacid RegimenNew England Journal of Medicine, 1977